SC-102

N/A

Report date: 2025/06/12 17:08:54
NME

Base Information

Drug NameSC-102
Drug Alias NameSC-102
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionEphrin type-A receptor 2 modulatorsTubulin inhibitors
TargetsEphrin type-A receptor 2Tubulin
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTianjin Conjustar Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Conjustar Biotechnology Co Ltd
Inactive CompaniesScancell
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A